pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Raze Therapeutics is discovering the next generation of oncology therapeutics that target metabolic pathways essential to cancer growth and survival – one-carbon (1C) metabolism.

LOCATION

  • Cambridge, MA, USA

    • THERAPEUTIC AREAS

  • Oncology

    • WEBSITE

    https://razetx.com/

    CAREER WEBSITE

    https://razetx.com/careers/

    SOCIAL MEDIA

    INVESTORS

    astellas-venture-management atlas-venture m-ventures mpm-capital ms-ventures novartis-venture-fund partners-innovation-fund

    PRESS RELEASES


    May 28, 2015

    Raze Therapeutics Announces Addition of Robert Copeland, PhD, to Scientific Advisory Board


    Apr 7, 2015

    Raze Therapeutics Appoints Mark Manfredi as Chief Scientific Officer


    Jan 7, 2015

    Raze Therapeutics Announces Addition of Julian Adams, PhD, George Q. Daley, MD, PhD, and Karen Vousden, PhD, to Scientific Advisory Board


    Oct 28, 2014

    Raze Therapeutics Appoints Mikel Moyer, PhD, as Vice President, Molecular Discovery


    Oct 14, 2014

    Raze Therapeutics Launches with $24 Million Series A Financing to Advance a New Class of Oncology Therapeutics Targeting Metabolic Pathways Essential to Cancer Growth and Survival


    For More Press Releases
    Google Analytics Alternative